Correlogic Systems and JEOL Sign Research and Development Agreement
News Jun 07, 2007
JEOL, headquartered in Tokyo, is a global manufacturer of scientific instruments used for research and development in the fields of nanotechnology, life sciences, optical communication, forensics, and biotechnology. Correlogic, based in Rockville, Maryland has pioneered the use of pattern recognition technologies for the development of proteomic, metabolomic, and genomic based clinical prognostic and clinical diagnostic tests.
Correlogic and JEOL have collaborated for more than a year under an informal agreement, and have made great strides in the continuing validation of various mass spectrometer-based assays. Details of the agreement were not released.
Over the past year, we have had a very close and productive research collaboration with JEOL," said Peter J. Levine, President and CEO of Correlogic Systems, Inc. "This agreement formalizes our link to one of the world's leading mass spectrometer and NMR manufacturers.
Pre-Filled Syringes & Injectable Drug Devices Europe
Jan 16 - Jan 17, 2019
3rd International Conference and Exhibition on Nanomedicine and Drug Delivery
Mar 13 - Mar 14, 2019